TickerFactsScreenerDevelopers

Intellia Therapeutics, Inc. (NTLA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $9.85M2015: $75.82M2016: $273.06M2017: $340.68M2018: $58.86M2019: $57.23M2020: $160.02M2021: $123.41M2022: $523.51M2023: $226.75M2024: $189.18M2025: $155.46M$155.46M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$155.46M-17.8%
2024$189.18M-16.6%
2023$226.75M-56.7%
2022$523.51M+324.2%
2021$123.41M-22.9%
2020$160.02M+179.6%
2019$57.23M-2.8%
2018$58.86M-82.7%
2017$340.68M+24.8%
2016$273.06M+260.2%
2015$75.82M+670.1%
2014$9.85M—